Clinical trials
Observational Pulmonary Arterial Hypertension trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2015 | 2 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 2 |
| Completed | 1 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 1 |
| KU Leuven | 1 |
| Paragonix Technologies | 1 |
| Pfizer | 1 |
| Technische Universität Dresden | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 6 |
| Hypertension, Pulmonary | 3 |
| Cystic Fibrosis | 1 |
| Eisenmenger Complex | 1 |
| Emphysema | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Inflammation | 1 |
| Lung Diseases, Interstitial | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
| Pulmonary Fibrosis | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.